DB18285ExperimentalProtein Based Therapies
AD-114: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on C-X-C chemokine receptor type 4
- Also known as
- Human single domain antibody-like protein inhibitor of the chemokine receptor type 4
- Code names
- AD-114
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with AD-114, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account